Package 68462-373-05

{"route": ["ORAL"], "spl_id": "d205c367-b32b-487d-9ede-00da4fba8397", "openfda": {"nui": ["N0000008486", "N0000185506", "N0000182140"], "upc": ["0368462374306", "0368462371305", "0368462372302", "0368462373309"], "unii": ["0H73WJJ391"], "rxcui": ["1494769", "1812419", "1812421", "1812425", "1812427"], "spl_set_id": ["54bfabce-1f8a-40ee-8b55-efce8fe6fbf1"], "pharm_class_pe": ["Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "pharm_class_moa": ["Cytochrome P450 3A4 Inducers [MoA]", "Cytochrome P450 2C19 Inhibitors [MoA]"], "manufacturer_name": ["Glenmark Pharmaceuticals Inc., USA"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "500 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (68462-373-05)", "package_ndc": "68462-373-05", "marketing_start_date": "20210201"}, {"sample": false, "description": "30 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (68462-373-30)", "package_ndc": "68462-373-30", "marketing_start_date": "20210201"}, {"sample": false, "description": "90 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (68462-373-90)", "package_ndc": "68462-373-90", "marketing_start_date": "20210201"}], "brand_name": "TOPIRAMATE", "product_id": "68462-373_d205c367-b32b-487d-9ede-00da4fba8397", "dosage_form": "CAPSULE, EXTENDED RELEASE", "pharm_class": ["Cytochrome P450 2C19 Inhibitors [MoA]", "Cytochrome P450 3A4 Inducers [MoA]", "Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "product_ndc": "68462-373", "generic_name": "topiramate", "labeler_name": "Glenmark Pharmaceuticals Inc., USA", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "TOPIRAMATE", "active_ingredients": [{"name": "TOPIRAMATE", "strength": "50 mg/1"}], "application_number": "ANDA210278", "marketing_category": "ANDA", "marketing_start_date": "20210201", "listing_expiration_date": "20271231"}